GNE-9815 is one of the most selective kinase inhibitors of RAF, targeting KRAS mutant cancers by combination of drugs.
|Solubility (25°C)||DMSO : 50 mg/mL|
Powder -20°C 3 years ; 4°C 2 years
In solvent -80°C 6 months ; -20°C 1 month
|Body Surface Area (m2)||0.007||0.025||0.15||0.05||0.02||0.5|
|Animal A (mg/kg) = Animal B (mg/kg) multiplied by||Animal B Km|
|Animal A Km|
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
|Related Raf Products|
|PROTAC RAF degrader 1
PROTAC RAF degrader 1 is a PROTAC RAF degrader.
|B-Raf IN 15
B-Raf IN 15 is a BRAF inhibitor.
|Raf inhibitor 3
Raf inhibitor 3 is a Raf inhibitor.
|B-Raf IN 16
B-Raf IN 16 is a BRAF inhibitors that belongs a cyclic iminopyrimidine derivative.
|B-Raf IN 13
B-Raf IN 13 is a BRAF inhibitor with an IC50 of 3.55 nM in BRAF V600E enzyme assay.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.